Cumberland Pharmaceuticals To Announce 2012 Year End Financial Results On February 28, 2013
Feb 14, 2013
|
|
|
 |
|
NASHVILLE, Tenn., Feb. 14, 2013 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release 2012 year-end financial results after the market closes on Thursday, February 28, 2013. A conference call and live Internet webcast will be held on Thursday, February 28, 2013, at 4:30 p.m. Eastern Time to discuss the...
|
|
Cumberland Pharmaceuticals And PT. SOHO Industri Pharmasi enter Into Exclusive Licensing Agreement For Caldolor In Indonesia
Jan 29, 2013
|
|
|
|
|
NASHVILLE, Tenn., Jan. 29, 2013 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) today announced it has entered into an exclusive agreement with Indonesia's PT. SOHO Industri Pharmasi (a SOHO Group company) for the registration and commercialization of Caldolor® (ibuprofen) Injection, which is used to treat pain and fever in the h...
|
|
Cumberland Emerging Technologies Expands Life Sciences Center
Dec 10, 2012
|
|
|
|
|
NASHVILLE, Tenn. (December 10, 2012) - Cumberland Emerging Technologies, Inc. (CET), a company formed to advance early-stage biomedical technologies and products from our Mid-South region to the marketplace, recently completed an expansion of its life sciences incubator. The project brings the facili...
|
|
Message from the CEO-3Q12 Overview
Nov 8, 2012
|
|
|
|
Cumberland Receives Second Acetadote® Patent Notice of Allowance
Nov 7, 2012
|
|
|
|
|
NASHVILLE, Tenn., Nov. 7, 2012 /PRNewswire/ -- Cumberland Pharmaceuticals Inc.(NASDAQ: CPIX) today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office for a second patent relating to its new formulation of Acetadote® (acetylcysteine) Injection, which is used to treat acetaminophen overdose. T...
|
|
Cumberland Pharmaceuticals Reports Third Quarter 2012 Financial Results
Nov 1, 2012
|
|
|
|
|
NASHVILLE, Tenn., Nov. 1, 2012 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced third quarter 2012 financial results.
Net Revenues: For the three months ended September 30, 2012, net revenues were $12.5 million, com...
|
|
Cumberland Pharmaceuticals to Announce Third Quarter 2012 Financial Results on November 1, 2012
Oct 18, 2012
|
|
|
|
|
NASHVILLE, Tenn., Oct. 18, 2012 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) announced today that it will release third quarter 2012 results after the market closes on Thursday, November 1, 2012. A conference call and live Internet webcast will be held on Thursday, November 1, at 4:30 p.m. Eastern Time to discuss the results.
...
|
|
CET Life Sciences Center Tenants Receive Federal Small Business Grant Awards
Oct 11, 2012
|
|
|
|
|
NASHVILLE, Tenn., Oct. 11, 2012 /PRNewswire/ -- Cumberland Emerging Technologies, Inc. (CET) today announced that three tenants at its Nashville Life Sciences Center have been awarded $3.2 million in federal small business grants. The grantees, wh...
|
|
|
|
